をクリックすると外部の論文のサイトが開きます。

研究業績に対する検索条件
※ スペース区切りで絞り込み検索が可能です。
研究業績タイプによる絞り込み条件です。絞り込みは行っていません。
論文
タイトル
タイトル(英)
SpCas9-HF1 enhances accuracy of cell cycle-dependent genome editing by increasing HDR efficiency, and by reducing off-target effects and indel rates.
参照URL
https://researchmap.jp/daisukematsumoto/published_papers/46299792
著者
著者(英)
Daisuke Matsumoto,Erina Matsugi,Kanae Kishi,Yuto Inoue,Kiyomi Nigorikawa,Wataru Nomura
担当区分
概要
概要(英)
In genome editing, it is important to avoid off-target mutations so as to reduce unexpected side effects, especially for therapeutic applications. Recently, several high-fidelity versions of SpCas9 have been developed to reduce off-target mutations. In addition to reducing off-target effects, highly efficient intended target gene correction is also essential to rescue protein functions that have been disrupted by single nucleotide polymorphisms. Homology-directed repair (HDR) corrects genes precisely using a DNA template. Our recent development of cell cycle-dependent genome editing has shown that regulation of Cas9 activation with an anti-CRISPR-Cdt1 fusion protein increases HDR efficiency and reduces off-target effects. In this study, to apply high-fidelity SpCas9 variants to cell cycle-dependent genome editing, we evaluated anti-CRISPR inhibition of high-fidelity SpCas9s. In addition, HDR efficiency of high-fidelity SpCas9s was addressed, identifying eSpCas9, SpCas9-HF1, and LZ3 Cas9 as promising candidates. Although eSpCas9 and LZ3 Cas9 showed decreased HDR efficiency in cell cycle-dependent genome editing, SpCas9-HF1 successfully achieved increased HDR efficiency and few off-target effects when co-expressed with an AcrIIA4-Cdt1 fusion.
出版者・発行元
出版者・発行元(英)
誌名
誌名(英)
Molecular therapy. Nucleic acids
35
1
開始ページ
102124
終了ページ
102124
出版年月
2024年3月12日
査読の有無
招待の有無
掲載種別
研究論文(学術雑誌)
ISSN
DOI URL
https://doi.org/10.1016/j.omtn.2024.102124
共同研究・競争的資金等の研究課題
研究者
松本 大亮 (マツモト ダイスケ)